Entera Bio Ltd
NASDAQ:ENTX
Gross Margin
Entera Bio Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Country | IL |
Market Cap | 83m USD |
Gross Margin | N/A |
Country | US |
Market Cap | 284.8B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 165.5B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 110.8B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 107.7B USD |
Gross Margin |
86%
|
Country | AU |
Market Cap | 135.2B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 84.2B USD |
Gross Margin |
76%
|
Country | US |
Market Cap | 48.1B USD |
Gross Margin |
22%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 32.8B USD |
Gross Margin |
75%
|
Country | KR |
Market Cap | 39.5T KRW |
Gross Margin |
48%
|
Profitability Report
View the profitability report to see the full profitability analysis for Entera Bio Ltd.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Entera Bio Ltd's most recent financial statements, the company has Gross Margin of 0%.